The DOI matches its Crossref record.
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Abstract
A strong candidate for the 17q-linked BRCA1 gene, which influences susceptibility to breast and ovarian cancer, has been identified by positional cloning methods. Probable predisposing mutations have been detected in five of eight kindreds presumed to segregate BRCA1 susceptibility alleles. The mutations include an 11-base pair deletion, a 1-base pair insertion, a stop codon, a missense substitution, and an inferred regulatory mutation. The BRCA1 gene is expressed in numerous tissues, including breast and ovary, and encodes a predicted protein of 1863 amino acids. This protein contains a zinc finger domain in its amino-terminal region, but is otherwise unrelated to previously described proteins. Identification of BRCA1 should facilitate early diagnosis of breast and ovarian cancer susceptibility in some individuals as well as a better understanding of breast cancer biology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 41
- American Cancer Society, Cancer Facts & Figures 1994: 13 (1994).
- ALTSCHUL, S.F., J MOL BIOL 215: 195 (1990).
- 10.1126/science.1321494 · DOI
- BOWCOCK, A.M., THRA1 AND D17S183 FLANK AN INTERVAL OF LESS-THAN-4 CM FOR THE BREAST-OVARIAN CANCER GENE (BRCA1) ON CHROMOSOME-17Q21, AMERICAN JOURNAL OF HUMAN GENETICS 52: 718 (1993).
- CAMPBELL, I.G., A NOVEL GENE ENCODING A B-BOX PROTEIN WITHIN THE BRCA1 REGION AT 17Q21.1, HUMAN MOLECULAR GENETICS 3: 589 (1994). · DOI
- CANNONALBRIGHT, L.A., FAMILIALITY OF CANCER IN UTAH, CANCER RESEARCH 54: 2378 (1994).
- CLAUS, E.B., GENETIC-ANALYSIS OF BREAST-CANCER IN THE CANCER AND STEROID-HORMONE STUDY, AMERICAN JOURNAL OF HUMAN GENETICS 48: 232 (1991).
- DRUMMOND, I.A., DNA RECOGNITION BY SPLICING VARIANTS OF THE WILMS-TUMOR SUPPRESSOR, WT1, MOLECULAR AND CELLULAR BIOLOGY 14: 3800 (1994).
- EASTON, D.F., GENETIC-LINKAGE ANALYSIS IN FAMILIAL BREAST AND OVARIAN-CANCER - RESULTS FROM 214 FAMILIES, AMERICAN JOURNAL OF HUMAN GENETICS 52: 678 (1993).
- FEUNTEUN, J, A BREAST-OVARIAN CANCER SUSCEPTIBILITY GENE MAPS TO CHROMOSOME-17Q21, AMERICAN JOURNAL OF HUMAN GENETICS 52: 736 (1993).
- FUTREAL, P.A., ISOLATION OF A DIVERGED HOMEOBOX GENE, MOX1, FROM THE BRCA1 REGION ON 17Q21 BY SOLUTION HYBRID CAPTURE, HUMAN MOLECULAR GENETICS 3: 1359 (1994). · doi:10.1093/hmg/3.8.1359
- 10.1126/science.7939630 · DOI · Paper page
- GOLDGAR, D.E., A LARGE KINDRED WITH 17Q-LINKED BREAST AND OVARIAN-CANCER - GENETIC, PHENOTYPIC, AND GENEALOGICAL ANALYSIS, JOURNAL OF THE NATIONAL CANCER INSTITUTE 86: 200 (1994). · doi:10.1093/jnci/86.3.200
- 10.1016/0092-8674(90)90690-G · DOI · Paper page
- 10.1126/science.2270482 · DOI · Paper page
- 10.1038/ng0994-22 · DOI · Paper page
- KELSELL, D.P., GENETIC-ANALYSIS OF THE BRCA1 REGION IN A LARGE BREAST OVARIAN FAMILY - REFINEMENT OF THE MINIMAL REGION CONTAINING BRCA1, HUMAN MOLECULAR GENETICS 2: 1823 (1993). · doi:10.1093/hmg/2.11.1823
- 10.1093/nar/15.20.8125 · DOI · Paper page
- LITTLE, M.H., EVIDENCE THAT WT1 MUTATIONS IN DENYS - DRASH SYNDROME PATIENTS MAY ACT IN A DOMINANT-NEGATIVE FASHION, HUMAN MOLECULAR GENETICS 2: 259 (1993). · doi:10.1093/hmg/2.3.259
- LITTLE, M.H., ZINC FINGER POINT MUTATIONS WITHIN THE WT1 GENE IN WILMS-TUMOR PATIENTS, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 89: 4791 (1992).
- LOVERING, R, IDENTIFICATION AND PRELIMINARY CHARACTERIZATION OF A PROTEIN MOTIF RELATED TO THE ZINC FINGER, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 90: 2112 (1993).
- LOVETT, M, DIRECT SELECTION - A METHOD FOR THE ISOLATION OF CDNAS ENCODED BY LARGE GENOMIC REGIONS, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 88: 9628 (1991).
- 10.1126/science.1978757 · DOI · Paper page
- METTLIN, C, THE ASSOCIATION OF AGE AND FAMILIAL RISK IN A CASE-CONTROL STUDY OF BREAST-CANCER, AMERICAN JOURNAL OF EPIDEMIOLOGY 131: 973 (1990). · doi:10.1093/oxfordjournals.aje.a115617
- 10.1016/0140-6736(91)90076-2 · DOI · Paper page
- Neuhausen, S., Cancer Research 54:6069 (1994).
- Neuhausen, S. L., Human Molecular Genetics 3: 1919 (1994). · DOI
- PATARCA, R, RPT-1, AN INTRACELLULAR PROTEIN FROM HELPER INDUCER T-CELLS THAT REGULATES GENE-EXPRESSION OF INTERLEUKIN 2 RECEPTOR AND HUMAN IMMUNODEFICIENCY VIRUS TYPE-1, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 85: 2733 (1988).
- SHAULIAN, E, IDENTIFICATION OF A MINIMAL TRANSFORMING DOMAIN OF P53 - NEGATIVE DOMINANCE THROUGH ABROGATION OF SEQUENCE-SPECIFIC DNA-BINDING, MOLECULAR AND CELLULAR BIOLOGY 12: 5581 (1992).
- SIMARD, J, GENETIC-MAPPING OF THE BREAST-OVARIAN CANCER SYNDROME TO A SMALL INTERVAL ON CHROMOSOME-17Q12-21 - EXCLUSION OF CANDIDATE GENES EDH17B2 AND RARA, HUMAN MOLECULAR GENETICS 2: 1193 (1993). · DOI
- Smith, H. S., Journal of Cellular Biochemistry 53 17G: 144 (1993). · doi:10.1002/jcb.240531128
- SMITH, T.F., IDENTIFICATION OF COMMON MOLECULAR SUBSEQUENCES, JOURNAL OF MOLECULAR BIOLOGY 147: 195 (1981). · DOI · Paper page
- SRIVASTAVA, S, DOMINANT-NEGATIVE EFFECT OF A GERM-LINE MUTANT P53 - A STEP FOSTERING TUMORIGENESIS, CANCER RESEARCH 53: 4452 (1993).
- SU, L.K., ASSOCIATION BETWEEN WILD-TYPE AND MUTANT APC GENE-PRODUCTS, CANCER RESEARCH 53: 2728 (1993).
- SWIFT, M, MALIGNANT NEOPLASMS IN FAMILIES OF PATIENTS WITH ATAXIA-TELANGIECTASIA, CANCER RESEARCH 36: 209 (1976).
- 10.1056/NEJM199112263252602 · DOI · Paper page
- TAKAHASHI, M, DEVELOPMENTALLY REGULATED EXPRESSION OF A HUMAN FINGER - CONTAINING GENE ENCODED BY THE 5' HALF OF THE RET TRANSFORMING GENE, MOLECULAR AND CELLULAR BIOLOGY 8: 1853 (1988).
- Thomas, A., IMA journal of mathematics applied in medicine and biology. 11: 149 (1994). · DOI
- WEAVERFELDHAUS, J, LOCALIZATION OF A PUTATIVE TUMOR-SUPPRESSOR GENE BY USING HOMOZYGOUS DELETIONS IN MELANOMAS, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 91: 7563 (1994).
- Westin, G., Proceedings of the National Academy of Sciences of the United States of America 81: 3811 (1984).
- 10.1126/science.8091231 · DOI · Paper page
Cited by
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs
Altschul, S. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.17.3389 · Cited by 73,302
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
European Association for the Study of the Liver, & European Organisation for Research and Treatment of Cancer (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.001 · Cited by 5,218
“This is the case of mutations in BRCA1 or BRCA2 and increased risk of breast or ovarian cancer [30] or in genes involved in DNA mismatch repair and hereditary colon cancer [31].”
BackgroundAntoniou, A., Pharoah, P. D. P., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Loman, N., Olsson, H., Johannsson, O., Borg, Å., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375033 · Cited by 3,680
Self-citationGenome-wide association study identifies novel breast cancer susceptibility loci
Easton, D. F., Pooley, K. A., Dunning, A. M., Pharoah, P. D. P., Thompson, D., Ballinger, D. G., Struewing, J. P., Morrison, J., Field, H., Luben, R., et al. (2007) · Nature · doi:10.1038/nature05887 · Cited by 2,319
Audeh, M. W., Carmichael, J., Penson, R. T., Friedlander, M., Powell, B., Bell-McGuinn, K. M., Scott, C., Weitzel, J. N., Oaknin, A., Loman, N., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60893-8 · Cited by 2,279
DNA repair pathways as targets for cancer therapy
Helleday, T., Petermann, E., Lundin, C., Hodgson, B., & Sharma, R. A. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2342 · Cited by 1,666
Tutt, A., Robson, M., Garber, J. E., Domchek, S. M., Audeh, M. W., Weitzel, J. N., Friedlander, M., Arun, B., Loman, N., Schmutzler, R. K., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60892-6 · Cited by 1,655
Botstein, D., & Risch, N. (2003) · Nature Genetics · doi:10.1038/ng1090 · Cited by 1,503
Association of BRCA1 with Rad51 in Mitotic and Meiotic Cells
Scully, R., Chen, J., Plug, A., Xiao, Y., Weaver, D., Feunteun, J., Ashley, T., & Livingston, D. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81847-4 · Cited by 1,459
Germline Mutations in Predisposition Genes in Pediatric Cancer
Zhang, J., Walsh, M. F., Wu, G., Edmonson, M. N., Gruber, T. A., Easton, J., Hedges, D., Ma, X., Zhou, X., Yergeau, D. A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1508054 · Cited by 1,345
“dominant (60 genes) and autosomal recessive (29) can-”
BackgroundPromoter Hypermethylation and BRCA1 Inactivation in Sporadic Breast and Ovarian Tumors
Esteller, M. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.7.564 · Cited by 1,233
State-of-the-art strategies for targeting the DNA damage response in cancer
Pilié, P. G., Tang, C., Mills, G. B., & Yap, T. A. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0114-z · Cited by 1,189
Wang, Y., Cortez, D., Yazdi, P., Neff, N., Elledge, S. J., & Qin, J. (2000) · Genes & Development · doi:10.1101/gad.14.8.927 · Cited by 1,221
Key steps for effective breast cancer prevention
Britt, K. L., Cuzick, J., & Phillips, K.-A. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0266-x · Cited by 992
BRCA1 and BRCA2: 1994 and beyond
Narod, S. A., & Foulkes, W. D. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1431 · Cited by 967
Self-citationRING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination
Lorick, K. L., Jensen, J. P., Fang, S., Ong, A. M., Hatakeyama, S., & Weissman, A. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11364 · Cited by 981
Breast Cancer after Prophylactic Bilateral Mastectomy in Women with a BRCA1 or BRCA2 Mutation
Meijers-Heijboer, H., van Geel, B., van Putten, W. L. J., Henzen-Logmans, S. C., Seynaeve, C., Menke-Pluymers, M. B. E., Bartels, C. C. M., Verhoog, L. C., van den Ouweland, A. M. W., Niermeijer, M. F., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107193450301 · Cited by 973
Burke, W. (1997) · JAMA · doi:10.1001/jama.277.12.997 · Cited by 955
Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage
Scully, R., Chen, J., Ochs, R. L., Keegan, K., Hoekstra, M., Feunteun, J., & Livingston, D. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80503-6 · Cited by 900
Androgen Receptor (AR) Coregulators: An Overview
Heinlein, C. A., & Chang, C. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.2.0460 · Cited by 943
Homologous Recombination and Human Health: The Roles of BRCA1, BRCA2, and Associated Proteins
Prakash, R., Zhang, Y., Feng, W., & Jasin, M. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016600 · Cited by 869
Accurate classification of BRCA1 variants with saturation genome editing
Findlay, G. M., Daza, R. M., Martin, B., Zhang, M. D., Leith, A. P., Gasperini, M., Janizek, J. D., Huang, X., Starita, L. M., & Shendure, J. (2018) · Nature · doi:10.1038/s41586-018-0461-z · Cited by 843
Henderson, B. E., & Feigelson, H. S. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.427 · Cited by 821
Substrate Specificities and Identification of Putative Substrates of ATM Kinase Family Members
Kim, S.-T., Lim, D.-S., Canman, C. E., & Kastan, M. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.53.37538 · Cited by 810
American Cancer Society Guidelines for Breast Cancer Screening: Update 2003
Smith, R. A., Saslow, D., Andrews Sawyer, K., Burke, W., Costanza, M. E., Evans, W. P., Foster, R. S., Hendrick, E., Eyre, H. J., & Sener, S. (2003) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.53.3.141 · Cited by 770
Yoshida, K., & Miki, Y. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb02195.x · Cited by 753
Self-citationEfficacy of Bilateral Prophylactic Mastectomy in BRCA1 and BRCA2 Gene Mutation Carriers
Hartmann, L. C., Sellers, T. A., Schaid, D. J., Frank, T. S., Soderberg, C. L., Sitta, D. L., Frost, M. H., Grant, C. S., Donohue, J. H., Woods, J. E., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.21.1633 · Cited by 743
Lakhani, S. R., Jacquemier, J., Sloane, J. P., Gusterson, B. A., Anderson, T. J., van de Vijver, M. J., Farid, L. M., Venter, D., Antoniou, A., Storfer-Isser, A., et al. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.15.1138 · Cited by 707
Self-citationIntegration of the extranuclear and nuclear actions of estrogen
Levin, E. R. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0390 · Cited by 708
Principles of Protein−Protein Interactions: What are the Preferred Ways For Proteins To Interact?
Keskin, O., Gursoy, A., Ma, B., & Nussinov, R. (2008) · Chemical Reviews · doi:10.1021/cr040409x · Cited by 697
Cantor, S. B., Bell, D. W., Ganesan, S., Kass, E. M., Drapkin, R., Grossman, S., Wahrer, D. C. R., Sgroi, D. C., Lane, W. S., Haber, D. A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00304-x · Cited by 674
In search of the tumour-suppressor functions of BRCA1 and BRCA2
Scully, R., & Livingston, D. M. (2000) · Nature · doi:10.1038/35044000 · Cited by 643
BRCA1 and BRCA2 and the genetics of breast and ovarian cancer
Welcsh, P. L. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.7.705 · Cited by 648
Association of BRCA1 with the hRad50-hMre11-p95 Complex and the DNA Damage Response
Zhong, Q., Chen, C.-F., Li, S., Chen, Y., Wang, C.-C., Xiao, J., Chen, P.-L., Sharp, Z. D., & Lee, W.-H. (1999) · Science · doi:10.1126/science.285.5428.747 · Cited by 626
The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistance
Bouwman, P., & Jonkers, J. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3342 · Cited by 615
Stratton, M. R. (1997) · The Lancet · doi:10.1016/s0140-6736(96)10109-4 · Cited by 579
Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1
Zheng, W., Long, J., Gao, Y.-T., Li, C., Zheng, Y., Xiang, Y.-B., Wen, W., Levy, S., Deming, S. L., Haines, J. L., et al. (2009) · Nature Genetics · doi:10.1038/ng.318 · Cited by 541
Association of Type and Location of BRCA1 and BRCA2 Mutations With Risk of Breast and Ovarian Cancer
Rebbeck, T. R., Mitra, N., Wan, F., Sinilnikova, O. M., Healey, S., McGuffog, L., Mazoyer, S., Chenevix-Trench, G., Easton, D. F., Antoniou, A. C., et al. (2015) · JAMA · doi:10.1001/jama.2014.5985 · Cited by 521
Self-citationBRCA1 required for transcription-coupled repair of oxidative DNA damage
Gowen, L. C., Avrutskaya, A. V., Latour, A. M., Koller, B. H., & Leadon, S. A. (1998) · Science · doi:10.1126/science.281.5379.1009 · Cited by 496
RetractedThe emerging landscape of breast cancer susceptibility
Stratton, M. R., & Rahman, N. (2008) · Nature Genetics · doi:10.1038/ng.2007.53 · Cited by 487
Franke, L., Bakel, H. V., Fokkens, L., de Jong, E. D., Egmont-Petersen, M., & Wijmenga, C. (2006) · The American Journal of Human Genetics · doi:10.1086/504300 · Cited by 476
Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1
Verhoog, L., Brekelmans, C., Seynaeve, C., van den Bosch, L., Dahmen, G., van Geel, A., Tilanus-Linthorst, M., Bartels, C., Wagner, A., van den Ouweland, A., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(97)07065-7 · Cited by 452
BRCA1–BARD1 promotes RAD51-mediated homologous DNA pairing
Zhao, W., Steinfeld, J. B., Liang, F., Chen, X., Maranon, D. G., Jian Ma, C., Kwon, Y., Rao, T., Wang, W., Sheng, C., et al. (2017) · Nature · doi:10.1038/nature24060 · Cited by 393
Jonasson, J. M., Ljung, R., Talbäck, M., Haglund, B., Gudbjörnsdòttir, S., & Steineck, G. (2009) · Diabetologia · doi:10.1007/s00125-009-1444-2 · Cited by 412
Addictions neuroclinical assessment: a neuroscience-based framework for addictive disorders
Kwako, L. E., Momenan, R., Litten, R. Z., Koob, G. F., & Goldman, D. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.10.024 · Cited by 395
Kurian, A. W., Ward, K. C., Howlader, N., Deapen, D., Hamilton, A. S., Mariotto, A., Miller, D., Penberthy, L. S., & Katz, S. J. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.01854 · Cited by 387
Hereditary breast and ovarian cancer: new genes in confined pathways
Nielsen, F. C., van Overeem Hansen, T., & Sørensen, C. S. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.72 · Cited by 367
Powell, S. N., & Kachnic, L. A. (2003) · Oncogene · doi:10.1038/sj.onc.1206678 · Cited by 364
Catteau, A., Harris, W. H., Xu, C.-F., & Solomon, E. (1999) · Oncogene · doi:10.1038/sj.onc.1202509 · Cited by 354
Deconstructing the sources of genotype-phenotype associations in humans
Young, A. I., Benonisdottir, S., Przeworski, M., & Kong, A. (2019) · Science · doi:10.1126/science.aax3710 · Cited by 288
Robson, M. E., Chappuis, P. O., Satagopan, J., Wong, N., Boyd, J., Goffin, J. R., Hudis, C., Roberge, D., Norton, L., Bégin, L. R., et al. (2003) · Breast Cancer Research · doi:10.1186/bcr658 · Cited by 307
Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status
Haffty, B. G., Harrold, E., Khan, A. J., Pathare, P., Smith, T. E., Turner, B. C., Glazer, P. M., Ward, B., Carter, D., Matloff, E., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08434-9 · Cited by 307
Triple‐negative breast cancer: Present challenges and new perspectives
Podo, F., Buydens, L. M. C., Degani, H., Hilhorst, R., Klipp, E., Gribbestad, I. S., Van Huffel, S., W.M. van Laarhoven, H., Luts, J., Monleon, D., et al. (2010) · Molecular Oncology · doi:10.1016/j.molonc.2010.04.006 · Cited by 299
Cao, L., Li, W., Kim, S., Brodie, S. G., & Deng, C.-X. (2003) · Genes & Development · doi:10.1101/gad.1050003 · Cited by 293
Paull, T. T., Cortez, D., Bowers, B., Elledge, S. J., & Gellert, M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111125998 · Cited by 282
The role of BRCA1 in DNA damage response
Wu, J., Lu, L.-Y., & Yu, X. (2010) · Protein & Cell · doi:10.1007/s13238-010-0010-5 · Cited by 235
Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1
Williams, R. S., Lee, M. S., Hau, D. D., & Glover, J. N. M. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb776 · Cited by 230
BRCA1 Induces Antioxidant Gene Expression and Resistance to Oxidative Stress
Bae, I., Fan, S., Meng, Q., Rih, J. K., Kim, H. J., Kang, H. J., Xu, J., Goldberg, I. D., Jaiswal, A. K., & Rosen, E. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1119 · Cited by 222
The search for genes contributing to endometriosis risk
Montgomery, G. W., Nyholt, D. R., Zhao, Z. Z., Treloar, S. A., Painter, J. N., Missmer, S. A., Kennedy, S. H., & Zondervan, K. T. (2008) · Human Reproduction Update · doi:10.1093/humupd/dmn016 · Cited by 211
Therapeutic Potential of Combining PARP Inhibitor and Immunotherapy in Solid Tumors
Vikas, P., Borcherding, N., Chennamadhavuni, A., & Garje, R. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00570 · Cited by 179
Single-cell morphology encodes metastatic potential
Wu, P.-H., Gilkes, D. M., Phillip, J. M., Narkar, A., Cheng, T. W.-T., Marchand, J., Lee, M.-H., Li, R., & Wirtz, D. (2020) · Science Advances · doi:10.1126/sciadv.aaw6938 · Cited by 177
Lodder, L. N., Frets, P. G., Trijsburg, R. W., Meijers-Heijboer, E. J., Klijn, J. G., Seynaeve, C., van Geel, A. N., Tilanus, M. M., Bartels, C. C., Verhoog, L. C., et al. (2002) · Breast Cancer Research and Treatment · doi:10.1023/a:1015269620265 · Cited by 175
Structure of the BRCT Repeats of BRCA1 Bound to a BACH1 Phosphopeptide
Shiozaki, E. N., Gu, L., Yan, N., & Shi, Y. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00238-2 · Cited by 174
Xie, D., Miller, C. W., O'Kelly, J., Nakachi, K., Sakashita, A., Said, J. W., Gornbein, J., & Koeffler, H. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009755200 · Cited by 146
Heijink, A. M., Talens, F., Jae, L. T., van Gijn, S. E., Fehrmann, R. S. N., Brummelkamp, T. R., & van Vugt, M. A. T. M. (2019) · Nature Communications · doi:10.1038/s41467-018-07927-y · Cited by 140
Genetic approaches to stature, pubertal timing, and other complex traits
Palmert, M. R., & Hirschhorn, J. N. (2003) · Molecular Genetics and Metabolism · doi:10.1016/s1096-7192(03)00107-0 · Cited by 135
Psychosocial sequelae of breast cancer and its treatment
Moyer, A., & Salovey, P. (1996) · Annals of Behavioral Medicine · doi:10.1007/bf02909583 · Cited by 129
Disabled-2 inactivation is an early step in ovarian tumorigenicity
Fazili, Z., Sun, W., Mittelstaedt, S., Cohen, C., & Xu, X.-X. (1999) · Oncogene · doi:10.1038/sj.onc.1202649 · Cited by 116
Ringwald, J., Wochnowski, C., Bosse, K., Giel, K. E., Schäffeler, N., Zipfel, S., & Teufel, M. (2016) · Journal of Genetic Counseling · doi:10.1007/s10897-016-9949-6 · Cited by 114
Kumaraswamy, E., & Shiekhattar, R. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00961-07 · Cited by 110
Implications of genetic epidemiology for the prevention of substance use disorders
Merikangas, K. R., & Avenevoli, S. (2000) · Addictive Behaviors · doi:10.1016/s0306-4603(00)00129-5 · Cited by 110
Genetic Studies of the Etiology of Type 2 Diabetes in Pima Indians
Baier, L. J., & Hanson, R. L. (2004) · Diabetes · doi:10.2337/diabetes.53.5.1181 · Cited by 109
The role of BRCA1 in DNA double-strand repair: Past and present
Caestecker, K. W., & Van de Walle, G. R. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.11.013 · Cited by 108
Evans, D. G. R., van Veen, E. M., Byers, H. J., Wallace, A. J., Ellingford, J. M., Beaman, G., Santoyo-Lopez, J., Aitman, T. J., Eccles, D. M., Lalloo, F. I., et al. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.07.002 · Cited by 95
Vreeswijk, M. P. G., Kraan, J. N., van der Klift, H. M., Vink, G. R., Cornelisse, C. J., Wijnen, J. T., Bakker, E., van Asperen, C. J., & Devilee, P. (2009) · Human Mutation · doi:10.1002/humu.20811 · Cited by 98
Persky, S., Kaphingst, K. A., Condit, C. M., & McBride, C. M. (2007) · Genetics in Medicine · doi:10.1097/gim.0b013e318159a344 · Cited by 91
Mutation analysis of the CHK2gene in families with hereditary breast cancer
Allinen, M., Huusko, P., Mäntyniemi, S., Launonen, V, & Winqvist, R. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1858 · Cited by 85
The bipolar disorder phenome database: a resource for genetic studies
Potash, J. B., Toolan, J., Steele, J., Miller, E. B., Pearl, J., Zandi, P. P., Schulze, T. G., Kassem, L., Simpson, S. G., Lopez, V., et al. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06122045 · Cited by 80
EMBRACE, Rebbeck, T. R., HEBON, Friebel, T. M., Mitra, N., Wan, F., Chen, S., Andrulis, I. L., Apostolou, P., Arnold, N., et al. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0768-3 · Cited by 71
Self-citationFamily history and survival of young women with invasive breast carcinoma
Malone, K. E., Daling, J. R., Weiss, N. S., McKnight, B., White, E. E., & Voigt, L. F. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19961001)78:7<1417::aid-cncr7>3.0.co;2-h · Cited by 68
Hereditary breast cancer: From molecular pathology to tailored therapies
Tan, D. S. P., Marchiò, C., & Reis-Filho, J. S. (2008) · Journal of Clinical Pathology · doi:10.1136/jcp.2008.057950 · Cited by 60
Glover, J. N. M. (2006) · Familial Cancer · doi:10.1007/s10689-005-2579-z · Cited by 57
Attia, J., Ioannidis, J. P. A., Thakkinstian, A., McEvoy, M., Scott, R. J., Minelli, C., Thompson, J., Infante-Rivard, C., & Guyatt, G. (2009) · JAMA · doi:10.1001/jama.2008.993 · Cited by 55
Recent advances in microfluidic methods in cancer liquid biopsy
Iliescu, F. S., Poenar, D. P., Yu, F., Ni, M., Chan, K. H., Cima, I., Taylor, H. K., Cima, I., & Iliescu, C. (2019) · Biomicrofluidics · doi:10.1063/1.5087690 · Cited by 51
BRCA1- and BRCA2-related mutations: therapeutic implications in ovarian cancer
Pothuri, B. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt307 · Cited by 50
Survival and tumor characteristics of German hereditary breast cancer patients
Hamann, U., & Sinn, H.-P. (2000) · Breast Cancer Research and Treatment · doi:10.1023/a:1006350518190 · Cited by 48
Wei, L., Lan, L., Yasui, A., Tanaka, K., Saijo, M., Matsuzawa, A., Kashiwagi, R., Maseki, E., Hu, Y., Parvin, J. D., et al. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.02037.x · Cited by 48
NFBD1/MDC1, 53BP1 and BRCA1 have both redundant and unique roles in the ATM pathway
Wilson, K. A., & Stern, D. F. (2008) · Cell Cycle · doi:10.4161/cc.7.22.7102 · Cited by 43
Karppinen, S.-M., Erkko, H., Reini, K., Pospiech, H., Heikkinen, K., Rapakko, K., Syväoja, J. E., & Winqvist, R. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.05.030 · Cited by 42
Activation of estrogen receptor-α by the anion nitrite
Veselik, D. J., Divekar, S., Dakshanamurthy, S., Storchan, G. B., Turner, J. M. A., Graham, K. L., Huang, L., Stoica, A., & Martin, M. B. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2783 · Cited by 42
The European opposition against the BRCA gene patents
Matthijs, G. (2006) · Familial Cancer · doi:10.1007/s10689-005-2580-6 · Cited by 30
Familial aggregation of age-related macular degeneration in the Utah population
Luo, L., Harmon, J., Yang, X., Chen, H., Patel, S., Mineau, G., Yang, Z., Constantine, R., Buehler, J., Kaminoh, Y., et al. (2008) · Vision Research · doi:10.1016/j.visres.2007.11.013 · Cited by 26
Lobb, E., & Meiser, B. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16393-9 · Cited by 23
Kar, S. P., Considine, D. P. C., Tyrer, J. P., Plummer, J. T., Chen, S., Dezem, F. S., Barbeira, A. N., Rajagopal, P. S., Rosenow, W. T., Moreno, F., et al. (2021) · Human Genetics and Genomics Advances · doi:10.1016/j.xhgg.2021.100042 · Cited by 18
Tumour spectrum in non-BRCA hereditary breast cancer families in Sweden
Wendt, C., Lindblom, A., Arver, B., von Wachenfeldt, A., & Margolin, S. (2015) · Hereditary Cancer in Clinical Practice · doi:10.1186/s13053-015-0036-z · Cited by 16
Ivy, S. P., Kunos, C. A., Arnaldez, F. I., & Kohn, E. C. (2019) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2019.1657403 · Cited by 11
Computational studies on the functional and structural impact of pathogenic mutations in enzymes
Dissanayake, U. C., Roy, A., Maghsoud, Y., Polara, S., Debnath, T., & Cisneros, G. A. (2025) · Protein Science · doi:10.1002/pro.70081 · Cited by 8
Metadata
- Authors
- Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., Bell, R., Rosenthal, J., Hussey, C., Tran, T., McClure, M., Frye, C., Hattier, T., Phelps, R., Haugen-Strano, A., Katcher, H., Yakumo, K., Gholami, Z., Shaffer, D., Stone, S., Bayer, S., Wray, C., Bogden, R., Dayananth, P., Ward, J., Tonin, P., Narod, S., Bristow, P. K., Norris, F. H., Helvering, L., Morrison, P., Rosteck, P., Lai, M., Barrett, J. C., Lewis, C., Neuhausen, S., Cannon-Albright, L., Goldgar, D., Wiseman, R., Kamb, A., & Skolnick, M. H.
- Venue
- Science
- Published
- 1994-10-07
- Volume
- 266
- Issue
- 5182
- Pages
- 66-71
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2109465247
- Cited by
- 6,071
- References
- 0
- FWCI
- 138.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.